Geneva, Aug. 17 -- International Clinical Trials Registry received information related to the study (ChiCTR2600129668) titled 'A Study of Probiotic Powder as an Add-on Treatment for Depression With Anhedonia' on Aug. 7.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: Beijing An Ding Hospital, Capital Medical University
Condition:
Major depressive disorder with anhedonia
Intervention:
Placebo group:Escitalopram plus matching placebo powder
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-08-15
Target Sample Size: Placebo group:39;Probiotic group:39;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=337128
Published by HT D...